Background Image
Table of Contents Table of Contents
Previous Page  21 / 64 Next Page
Information
Show Menu
Previous Page 21 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 5, September/October 2020

AFRICA

241

Effect of heroin on right ventricular cardiac performance

Murat Selcuk, Ersin Yildirim, Faysal Saylik, Ozgur Deniz, Ferit Onur Mutluer

Abstract

Objective:

The aim of this study was to investigate the effects

of heroin addiction, which is an important social and health

problem, on right cardiac function.

Methods:

A total of 85 individuals were included in the

study. The study group comprised 45 patients smoking

heroin and the control group was 40 healthy individuals with

no drug addiction. Patients injecting heroin were excluded.

Echocardiographic evaluation of patients using heroin was

performed and compared with those in the control group.

Results:

The right ventricle and pulmonary artery diameters

in the heroin group were found to be higher compared to the

control group. The myocardial performance index (MPI) was

higher and more abnormal in the heroin group (0.48

±

0.22 vs

0.39

±

0.11,

p

< 0.05) whereas isovolumic acceleration (IVA)

of the right ventricle was significantly lower in the heroin

group (2.92

±

0.69 vs 3.4

±

0.68 m/s

2

,

p

< 0.01). No significant

difference was observed between the groups with regard to the

right ventricular ejection fraction (RVEF) (59.6

±

2.5 vs 60.6

±

2.3%,

p

= 0.08), tricuspid annular plain systolic excursion

(TAPSE) (24.1

±

4.2 vs 24.5

±

2.4 mm,

p

= 0.7), tissue Doppler

imaging S wave (TDI-S) (13.7

±

2.1 vs 13.8

±

2.1 cm/s,

p

=

0.86) and right ventricular fractional area change (RVFAC)

(42.7

±

8.3 vs 43.9

±

3.5%,

p

= 0.4). Multivariate and univari-

ate regression analyses revealed independent correlation

between the pulmonary artery diameter and RVIVA, and

heroin addiction.

Conclusion:

Heroin addiction negatively affected right ventric-

ular function and more attention should be paid to the

cardiac function of these patients.

Keywords:

heroin, right ventricular function, myocardial perfor-

mance index

Submitted 17/11/19, accepted 27/1/20

Published online 5/3/20

Cardiovasc J Afr

2020;

31

: 241–244

www.cvja.co.za

DOI: 10.5830/CVJA-2020-002

Heroin addiction is one of the most destructive and expensive

public health problems. Heroin, which is a central nervous

system depressant (diacetylmorphine), is a semi-synthetic opiate.

Mortality rate among heroin users varies between 1 and 3%,

and the most effective treatment method for heroin addiction

is opioid replacement therapy.

1,2

Heroin is commonly smoked,

snorted and injected intravenously.

A common negative effect of heroin addiction is respiratory

depression, which may lead to death, especially following

intravenous (IV) injection. Additionally, heroin-related

pulmonary oedema has been reported in previous studies.

3

IV use of the drug is difficult to evaluate since the injection is

generally performed together with other chemical substances

named adulterants.

4

Heroin addiction is a serious social health problem. We

evaluated patients who smoked heroin and aimed to investigate

its effect on right heart function since not much is known about

the cardiac effect of heroin addiction.

Methods

Informed consent was obtained from all patients and they signed

a consent form to participate in the study. The Van Education

and Research Hospital ethics committee approved the study.

A total of 85 individuals were included in the study. The study

group comprised 45 patients smoking heroin and undergoing

therapy in the Alcohol and Drug Addiction Treatment and

Training Centre of the Van Training and Research Hospital

between 2014 and 2016. The control group consisted of 40

healthy individuals with no drug addiction other than smoking

cigarettes.

Subjects who used heroin via the IV route, alcoholics, those

with coronary artery disease, cardiac failure, cardiac valve

disorders, known arrhythmias, hypertension, congenital cardiac

diseases, diabetes, hepatic or renal failure, chronic obstructive

pulmonary disease, endocrine diseases, metabolic or electrolyte

disorders, acute or chronic infections or those on medications

due to any type of disease, were excluded from the study.

The clinical and demographic characteristics of the patients,

and status and duration of heroin addiction were obtained from

the patients and patient files in the hospital. Body mass index,

defined as body mass divided by the square of the height, was

determined. Electrocardiography (ECG) records of the patients

were obtained via the Schiller Cardiovit AT-102 plus using the

standard 12 derivation (10 mm/mV calibration and 25 mm/s

sliding rate). Complete blood counts and biochemical tests were

performed using a Beckman Coulter LH-750 and Beckman

Coulter L × 20, respectively, and the results of each patient were

recorded.

Echocardiographic evaluations of the patients were performed

at the time of admission to our hospital while the patients were

still under the influence of heroin.

All participants underwent

two-dimensional (2D) andDoppler echocardiographic evaluation

(VIVID 3, General Electric, USA). 2D echocardiographic

Department of Cardiology, Van Education and Research

Hospital, University of Health Sciences, Van, Turkey

Murat Selcuk, MD,

Faysal Saylik,MD

Ferit Onur Mutluer, MD

Department of Cardiology, Istanbul Umraniye Education

and Research Hospital, University of Health Sciences,

Istanbul, Turkey

Ersin Yildirim, MD,

ersinyil44@gmail.com

Department of Psychiatry, Van Education and Research

Hospital, University of Health Sciences, Van, Turkey

Ozgur Deniz, MD